Evidence map›Paper›PMID 40507994›Full record

ArticleInternational journal of molecular sciences2025

Nanoscale Mechanical and Morphological Characterization of Ebolavirus-like Particles: Implications for Therapeutic Development.

Hannah Hargrove, Susana A Torres-Hurtado, Wendy J Maury, Xiaohui Frank Zhang

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hannah HargroveDepartment of Biomedical Engineering and Department of Chemical Engineering, University of Massachusetts Amherst, Amherst, MA 01003, USA.ORCID 0009-0002-4083-5689
Susana A Torres-HurtadoDepartment of Biomedical Engineering and Department of Chemical Engineering, University of Massachusetts Amherst, Amherst, MA 01003, USA.
Wendy J MauryDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA.ORCID 0000-0002-9892-4484
Xiaohui Frank ZhangDepartment of Biomedical Engineering and Department of Chemical Engineering, University of Massachusetts Amherst, Amherst, MA 01003, USA.ORCID 0000-0002-8778-595X

Funding

Biomechanics of TIM Protein-Mediated Ebola Virus-Host Cell AdhesionR15AI133634 · NIAID · LEHIGH UNIVERSITY · PI JAGOTA, ANAND, ZHANG, XIAOHUI · 2018 to 2018
$435k
Biophysical characterization of SARS-CoV-2 spike protein - receptor interactionsR21AI163708 · NIAID · LEHIGH UNIVERSITY · PI IM, WONPIL, ZHANG, XIAOHUI · 2021 to 2022
$426k
NIAID NIH HHS R15 AI133634NIAID NIH HHS R21 AI163708NIH HHS AI133634NIH HHS AI163708NSF CBET-2226779
6 · The paper itself

Abstract

Zaire Ebolavirus (EBOV) is one type of filovirus that causes the deadly EBOV disease, with an average fatality rate of around 50%. EBOV outbreaks are devastating and unpredictable and may emerge as the next global pandemic. As a BSL-4 pathogen, EBOV is inaccessible to regular biological laboratories. Therefore, EBOV virus-like particles (EBOV-VLPs) and EBOV pseudoviruses (EBOV-PVs) are utilized in the initial development of many potential therapies, for safety reasons and ease of procurement, as opposed to using infectious viruses. To investigate the host cell entry of EBOV and develop viral entry blockers, the EBOV model virions must accurately represent the morphological and mechanical properties of infectious EBOV virions. Due to the nanometer scale and irregular shape of EBOVs, these properties are challenging to characterize. In this research, state-of-the-art nanoscale characterization techniques are employed to examine the mechanical and structural elements of a selection of commonly used EBOV-approximating model virions. This study comprehensively determines the accuracy of EBOV approximation with a variety of model virions and the uniformity of mechanical and structural traits across different model virion types and preparation methods. This provides important implications for developing therapeutic treatments against EBOV using these model virions.

Indexed as

EbolavirusHemorrhagic Fever, EbolaVirionAnimalsHumansatomic force microscopy (AFM) imagingatomic force spectroscopyEbolavirusEBOVΔVP30EBOVΔVP40 VLPelastic modulus nanoindentationrVSV-EBOV-GPvirus-like particles (VLPs)

Identifiers

PMID40507994
PMCPMC12154113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.